Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,802,637
-
Share change
-
+203,890
-
Total reported value
-
$9,460,500
-
Price per share
-
$1.62
-
Number of holders
-
27
-
Value change
-
+$112,877
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q3 2018
As of 30 Sep 2018,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,802,637 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, CVI Holdings, LLC, Knoll Capital Management, LP, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., MACQUARIE GROUP LTD, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, ETF MANAGERS GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, and AMUNDI PIONEER ASSET MANAGEMENT INC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.